NeoGenomics, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $201.66Mn |
Net Profits | $2.24Mn |
Net Profit Margins | 1.11% |
NeoGenomics, Inc. Common Stock’s revenue jumped 11.21% since last year same period to $201.66Mn in the Q2 2026. On a quarterly growth basis, NeoGenomics, Inc. Common Stock has generated 8.03% jump in its revenue since last 3-months.
NeoGenomics, Inc. Common Stock’s net profit jumped 104.96% since last year same period to $2.24Mn in the Q2 2026. On a quarterly growth basis, NeoGenomics, Inc. Common Stock has generated 113.08% jump in its net profits since last 3-months.
NeoGenomics, Inc. Common Stock’s net profit margin jumped 104.46% since last year same period to 1.11% in the Q2 2026. On a quarterly growth basis, NeoGenomics, Inc. Common Stock has generated 112.11% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.05 |
EPS Estimate Current Year | 0.05 |
NeoGenomics, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a 183.33% jump from last quarter’s estimates.
NeoGenomics, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 0.05.
Key Ratios
Earning Per Share (EPS) | -0.01 |
NeoGenomics, Inc. Common Stock’s earning per share (EPS) fell -133.33% since last year same period to -0.01 in the Q2 2026. This indicates that the NeoGenomics, Inc. Common Stock has generated -133.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-07-28 | -0.06 | -0.01 | 83.33% |
2026-04-28 | 0.01 | 0.01 | -12.28% |
